Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis: The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study
J Am Coll Cardiol Rodriguez et al.
47: 1522
Online Appendix
Participants in ORAR II trial
Files in this Data Supplement:
|